Before Russia launched its full-scale invasion, Ukraine had one of the highest populations of people living with viral hepatitis in Europe. While the times of war increased the risks for infection, civil society is showing dedication to addressing the rising health concerns.
It was 1st June when a medical van stopped at Lozova, in Kharkiv oblast, Eastern Ukraine. Prior to Russia’s invasion, Lozova was home to 50,000 people – though the war has displaced over 30% of the country’s population, either internally or beyond Ukraine’s borders.
As the van stopped in the town, people started gathering around. The van is one of the six vans from the Alliance for Public Health in Ukraine that operate with medical teams aiming to address medical needs in the frontline territories as well as providing testing of viral infections.
During rapid testing for viral hepatitis C, two positive results were recorded – one for a 40-year-old woman, and the other for her 45-year-old husband. The following day another case was reported for a 37-year-old man in a different city – Shevchenkiv.
The unifying factor for the likelihood of infection, according to Iryna Filenko, a social worker of the Blago Foundation, was the local dentist in Kupyansk that they visited in the past six months.
“Perhaps the infection occurred there because this city is 8 km from the front. Frequent artillery fire. Frequent power outages. In the zone of active hostilities, non-compliance with the rules of instrument sterilisation is possible,” Filenko explained to EURACRIV.
The example Filenko gave encapsulates how wartimes increase the spread of viruses, such as hepatitis C. While sharing drug injection equipment is the driving risk for the virus spread, wartimes create new ways and new risk groups.
“In terms of injecting drug use, the risks remain as they were but they are higher now because people taking less care about sterility,” Tetiana Deshko, director of International Programs at Alliance for Public Health in Ukraine, told EURACTIV at the EASL liver congress in Vienna, Austria.
But frontlines create further risk groups, as there is a lot of blood contact among the military.
“I have to say military people are now so much affected by hepatitis,“ Deshko said, adding that so far there are no statistics on this available.
“We think that this is one of the gaps that the country would soon have to address more significantly,” she said.
Another risk group are sex workers, whose number increased in the frontline areas, according to Deshko, as destroyed industries have led to reduced employment opportunities.
Taking the increased risks of hepatitis spread into account, Ukraine is in a particularly difficult situation as “even before the war the situation with hepatitis was very challenging in Ukraine”. In the opening press conference of the EASL liver congress, Deshko said that an estimated 5% of the adult population lives with hepatitis C infection.
“It’s 1.3 million people, it’s a massive population,” she said.
Moreover, as viral hepatitis does not show symptoms until serious health complications occur, only one in 10 people infected with the hepatitis C virus are aware of their condition, Deshko said. Because of this, the disease is known as the “silent killer”.
Deshko’s organisation, the International Programs at Alliance for Public Health, responds to HIV, hepatitis and tuberculosis, going closer to communities with mobile units to ensure linkage to care to the risk groups. Since the war started, they also provide humanitarian help and general healthcare.
The group operates in frontline territories with a team of a doctor, a nurse, a social worker, and a driver. Among a number of medical tests available, they provide hepatitis C testing, as well as basic medications and hygiene products.
“First, you see no one,” Deshko started telling how the situation is when visiting with the mobile units.
“After 10 minutes, people start coming out from underground of their houses. And they’re often elderly people, but also young people. They say that they haven’t seen any medical worker for the last half a year or so. So they come with very basic needs,” she said.
The mobile units address a variety of medical needs, as access to healthcare is challenging in times of war – while at the same time providing a chance to diagnose people infected with hepatitis C.
“Health-seeking behaviour is very low in people. Especially men – when they offered rapid testing for hepatitis C, they would rather say no,” Deshko said.
“But if they are coming for humanitarian aid to get some things which are necessary for the home, while they are standing in the queue, there is time to persuade the person a little bit and really kind of motivate them to seek medical advice as well.”
However, diagnosis does not ensure treatment and with the majority of Ukraine’s budget dedicated to war, the situation still runs up against difficulties.
The Ukrainian government used to procure medications for treating between 16,000 and 18,000 patients with hepatitis C annually. However, currently, as 60% of the national budget is the war budget, according to Deshko, the number of treated patients was reduced to about 12,000 in 2022.
“It is largely because there are not enough medications to treat people and there are just too many structural barriers, populations are moving across the country. Some of the facilities are not available anymore as one in 10 health facilities in Ukraine has been either destroyed or damaged by Russian shelling,” she said.
When it comes to hepatitis treatment, of the 230 medical hospitals that offered treatment before the war, only around 80 are still offering the treatment.
While the Alliance for public health procured some medication, Deshko called it a “drop in the ocean”.
“War veterans are coming without hands and without legs. They have to have proper proteases but they also need to get the proper checks for hepatitis and other blood-borne infections,” Deshko urged.
“It’s so important that we think about this response now,” she said.
By Giedrė Peseckytė
Subscribe to EURACTIV’s Health Brief, where you’ll find the latest roundup of news covering health from across Europe. The Health Brief is brought to you by EURACTIV’s Health Team Giedrė Peseckytė, Clara Bauer-Babef, Marta Iraola, and Gerardo Fortuna.
This week’s podcast
European Health Data Space (EHDS) focuses on the primary and secondary use of data. While the primary use of data is data used by citizens and healthcare professionals at the national and EU levels the secondary data is to be used by researchers, policy makers and pharma. The Commission’s proposal does not include any say for patients regarding the secondary use of data, while Parliament, which is currently dealing with the proposal, is vowing for an opt-out option. In the meantime, there is a petition circling calling for the empowerment of patients regarding the secondary use of their health records. Regarding which concerns are being seen for the patients when it comes to the reuse of the health data, EURACTIV’s Giedre Peseckyte speaks with Jan Penfrat, the senior policy advisor at the European digital rights association.
Cancer cases doubled in France since 1990. According to the latest data from national health organisations, the increase in the number of cases in France can be explained mainly by the ageing and growth of the population. However, the emergence of new risk factors, linked in particular to climate change, a more sedentary lifestyle and greater exposure to UV rays, are also contributing to it.
Only seven EU countries recognise the right to be forgotten for former cancer patients. Despite efforts by EU Institutions, cancer survivors in the European Union continue to experience difficulties in accessing financial services like insurance or mortgages, years after successfully completing treatment.
EU’s new legislation gives EMCDDA more power. A new regulation of the European Parliament and the Council updated the mandate of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), according to a press release published on Friday (30 June) by EMCDDA. The future legislation will grant more power to the EMCDDA to better face the quick and complex changes in the drug landscape in Europe. It will come into application on 1 July 2024 and the EMCDDA will change its name to European Union Drugs Agency (EUDA). “In recent years, there has been an increasing disconnect between the complexity and developments of today’s drug phenomenon and the provision of the current mandate,” the press release reads. The future EUDA will focus more on three key areas: monitoring, preparedness and competence development for better interventions. “With a more proactive remit, adapted to the current reality, the new EUDA will be better equipped to support the EU and its Member States in addressing emerging issues in this field”, EMCDDA said. The new legislation initially comes from a proposal from the European Commission dated 12 January 2022.
The International Olympic Committee (IOC) lays out a Mental Health Action Plan. The organisation presented on Monday (3 July) a strategy to support the protection and promotion of mental well-being among athletes. The communication recognises that “athlete’s mental health needs are as important for their performance and well-being as their physical health needs”. The IOC has put in place certain key targets that aims to achieve by 2026 in order to guarantee good mental health in sports. For the implementation of this plan, the IOC will put in place expert-led tools to improve mental health literacy and encourage safe environments for athletes where they will be able to seek help and reduce stigma. According to the communication, the Olympic organisation will put special emphasis on addressing cross-cultural differences and sport-specific stressors.
New European network of vaccine manufacturers to better prepare for future health threats. The European Commission announced on Friday (30 June) a new network of vaccine manufacturers in the EU, “EU FAB”. The idea is to create a net of producers with capacities to respond to future health emergencies. This network will be financed by the Health Emergency and Response Authority (HERA) together with the European Health and Digital Executive Agency (HaDEA) and will receive €160 million per year. “EU FAB” will be able to quickly produce up to 325 million vaccines every year if needed in facilities in Belgium, Ireland, the Netherlands and Spain. The companies members of this network will be responsible for ensuring that facilities, staff and supply chains are maintained to enable them to quickly start manufacturing whenever the European Commission asks to do so.
The Aviation Health Safety Protocol that was in place during the COVID-19 pandemic officially ends its work. The European Centre for Disease Prevention and Control (ECDC) and the European Union Aviation Safety Agency (EASA) have formally withdrawn the safety protocol that was in place during the pandemic. After the World Health Organisation declared that COVID-19 is no longer a public health emergency in May 2023 and following the stable trends in the EU, the responsible health authorities consider that the protocol is no longer needed. The AHSP was first presented in May 2020 with the idea of implementing measures that allowed to ensure health safety in aviation, both for passengers and stakeholders, without endangering flight safety. According to both agencies, they will continue to work together to prevent similar situations to happen in the future.
The ECDC warns of an increase in legionnaires disease in Europe. The European Centre for Disease Prevention and Control (ECDC) published on Monday (3 July) a report that shows a rising number of cases of legionnaires disease, a form of pneumonia, in the EU during the year 2021, with more than 10,700 cases and 704 deaths reported. Only four countries – Italy, Spain, Germany and France – account for 75% of the cases. According to the ECDC, the causes of this increase are not clear, but it identifies some factors that can contribute to it, like changes in national testing policies, ageing population, conditions of water systems and changes in climate. The health agency recommends that public health authorities be vigilant and prepared to identify possible outbreaks.
Medicine regulatory agencies conclude that COVID-19 vaccines saved millions of lives and play a key role in tackling the pandemic. The International Coalition of Medicines Regulatory Authorities (IMCRA) affirmed the effectiveness of the COVID-19 vaccine by analysing long-term data obtained from the more than 13 billion doses administrated worldwide during the last two years. Health authorities determine that the vaccine helped to significantly reduce the risk of severe disease and death from COVID infection. While they recognise some rare serious side effects, it also concludes that the “benefits of the approved vaccines far outweigh the possible risks”. The statement issued by IMCRA also addresses the consequences of misinformation during the pandemic and debunks the idea that vaccines caused excess mortality.
LISBON
Portugal’s health minister calls for ‘prudence’ in decriminalisation of synthetic drugs. Portuguese Health Minister Manuel Pizarro called for ‘a lot of prudence’ in the process of decriminalising synthetic drugs to ensure that this ‘good idea’ does not end up disrupting the distinction between consumption and trafficking. By Sérgio Mourato | Lusa.pt
VALLETTA
Malta’s abortion law reform insufficient, critics say. Malta’s recent reform of the total ban on abortion in all circumstances to now allowing it in cases where the mother’s life is at risk is viewed by critics – including those in the EU Parliament – as a small and inadequate step towards safeguarding women’s reproductive rights. By Alice Taylor and Sofia Stuart Leeson | EURACTIV.com
5-7 July |WHO’s Seventh Ministerial Conference on Environment and Health
5 July |EU collaborative models to tackle childhood cancer in the EU Parliament
10-12 July |ENVI committee meeting in Strasbourg
11 July |Report ‘COVID-19 pandemic: lessons learned and recommendations for the future in Strasbourg’ vote in plenary, Strasbourg
12 July |WHO’s webinar on Alcohol and cancer
12 July |European Public Health Alliance (EPHA), webinar Planetary Health and Climate Justice
[Edited by Nathalie Weatherald]
